BR9906581A - Processo para administração de taxano encapsulado em lipossomos - Google Patents

Processo para administração de taxano encapsulado em lipossomos

Info

Publication number
BR9906581A
BR9906581A BR9906581-9A BR9906581A BR9906581A BR 9906581 A BR9906581 A BR 9906581A BR 9906581 A BR9906581 A BR 9906581A BR 9906581 A BR9906581 A BR 9906581A
Authority
BR
Brazil
Prior art keywords
liposomes
encapsulated
taxane
administration
taxane encapsulated
Prior art date
Application number
BR9906581-9A
Other languages
English (en)
Inventor
Aquilar Rahman
Original Assignee
Neopharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharm filed Critical Neopharm
Publication of BR9906581A publication Critical patent/BR9906581A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

<B>PROCESSO PARA ADMINISTRAçãO DE TAXANO ENCAPSULADO EM LIPOSSOMOS<D> é provido taxano encapsulado em lipossomos ou um derivado antineoplástico ou mistura do mesmo, que é empregado para efetuar um processo terapeuticamente aperfeiçoado para o tratamento do câncer. O paclitaxel encapsulado em lipossomos permite a administração a um paciente, especificamente um paciente humano, em menos de uma hora, sem toxicidade substancial.
BR9906581-9A 1998-07-01 1999-06-29 Processo para administração de taxano encapsulado em lipossomos BR9906581A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/108,509 US6146659A (en) 1998-07-01 1998-07-01 Method of administering liposomal encapsulated taxane
PCT/US1999/014986 WO2000001366A1 (en) 1998-07-01 1999-06-29 A method of administering liposomal encapsulated taxane

Publications (1)

Publication Number Publication Date
BR9906581A true BR9906581A (pt) 2000-09-26

Family

ID=22322617

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9906581-9A BR9906581A (pt) 1998-07-01 1999-06-29 Processo para administração de taxano encapsulado em lipossomos

Country Status (17)

Country Link
US (1) US6146659A (pt)
EP (1) EP1009384A4 (pt)
JP (2) JP2001524990A (pt)
KR (1) KR20010023522A (pt)
CN (1) CN1275076A (pt)
AU (1) AU730599B2 (pt)
BR (1) BR9906581A (pt)
CA (1) CA2301057C (pt)
EA (1) EA003678B1 (pt)
HU (1) HUP0004583A3 (pt)
IL (1) IL134747A0 (pt)
NO (1) NO20001012L (pt)
NZ (1) NZ524490A (pt)
PL (1) PL338951A1 (pt)
SK (1) SK4642000A3 (pt)
TR (1) TR200000576T1 (pt)
WO (1) WO2000001366A1 (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087954A1 (en) * 1997-01-07 2003-05-08 Sonus Pharmaceuticals, Inc. Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7112338B2 (en) * 1997-03-12 2006-09-26 The Regents Of The University Of California Cationic liposome delivery of taxanes to angiogenic blood vessels
US7262173B2 (en) * 1997-03-21 2007-08-28 Georgetown University Chemosensitizing with liposomes containing oligonucleotides
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US7314637B1 (en) * 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US6461637B1 (en) * 2000-09-01 2002-10-08 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US7915238B2 (en) * 1999-02-01 2011-03-29 Eisai R & D Management Co., Ltd. Immunomodulatory compounds and methods of use thereof
US20040006242A1 (en) * 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
US6835721B2 (en) * 1999-02-01 2004-12-28 Eisai Co., Ltd. Immunomodulatory compounds and methods of use thereof
USRE43914E1 (en) * 1999-06-09 2013-01-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Method for detecting syphilis using synthetic antigens
CZ2002850A3 (cs) * 1999-09-09 2003-04-16 The Regents Of The University Of California Kationtový liposom a použití kationtového liposomového prostředku
AR030188A1 (es) * 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
EP1259225B1 (en) * 2000-02-04 2006-10-04 Lipoxen Technologies Limited Process of dehydration/rehydration for making liposomes
US20030129223A1 (en) * 2000-10-11 2003-07-10 Targesome, Inc. Targeted multivalent macromolecules
US20030133972A1 (en) * 2000-10-11 2003-07-17 Targesome, Inc. Targeted multivalent macromolecules
BR0115260A (pt) 2000-11-09 2005-08-16 Neopharm Inc Complexos de sn-38 com lipìdeos e seus usos no tratamento de doenças
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
CA2354486A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C7 ester substituted taxanes
WO2003018018A2 (en) * 2001-08-24 2003-03-06 Neopharm, Inc. Vinorelbine compositions and methods of use
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
EP1448237A1 (en) * 2001-11-09 2004-08-25 Neopharm, Inc. Selective treatment of il-13 expressing tumors
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
AU2003234670B2 (en) 2002-05-24 2010-06-10 Angiotech International Ag Compositions and methods for coating medical implants
WO2003102011A1 (en) * 2002-05-29 2003-12-11 Neopharm, Inc. Method for determining oligonucleotide concentration
DK1521572T3 (da) * 2002-07-15 2009-05-04 Alcon Inc Biologisk nedbrydelig film til indförsel af öjenlægemiddel
KR100533458B1 (ko) 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
WO2004017944A1 (en) * 2002-08-23 2004-03-04 Neopharm, Inc. Liposomal gemcitabine compositions for better drug delivery
WO2004069224A2 (en) * 2003-02-03 2004-08-19 Neopharm, Inc. Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
EA200501285A1 (ru) * 2003-02-11 2006-02-24 Неофарм, Инк. Способ получения липосомальных препаратов
WO2004087758A2 (en) * 2003-03-26 2004-10-14 Neopharm, Inc. Il 13 receptor alpha 2 antibody and methods of use
US20060165744A1 (en) * 2003-05-22 2006-07-27 Neopharm, Inc Combination liposomal formulations
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
US20080063699A1 (en) * 2003-10-15 2008-03-13 Michael Teifel Method of Administering Cationic Liposomes Comprising an Active Drug
TW200540164A (en) 2004-03-05 2005-12-16 Univ Florida State Res Found C7 lactyloxy-substituted taxanes
US8022279B2 (en) * 2004-04-22 2011-09-20 Celator Pharmaceuticals, Inc. Liposomal formulations of anthracycline agents and cytidine analogs
JP4433918B2 (ja) * 2004-07-15 2010-03-17 コニカミノルタエムジー株式会社 画像形成方法
JP2008518925A (ja) * 2004-10-29 2008-06-05 ネオファーム、インコーポレイティッド リポソーム製剤の製造プロセス
US8178129B2 (en) 2004-11-02 2012-05-15 Tel-Aviv University Future Technology Development L.P. Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
US20070292418A1 (en) * 2005-04-26 2007-12-20 Eisai Co., Ltd. Compositions and methods for immunotherapy
WO2006116423A2 (en) 2005-04-26 2006-11-02 Eisai Co., Ltd Compositions and methods for cancer immunotherapy
US9233094B2 (en) 2005-05-04 2016-01-12 Medigene Ag Method of administering a cationic liposomal preparation
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.
CA2648939C (en) 2006-04-20 2014-07-08 Amgen Inc. Stable emulsion formulations
US9637515B2 (en) 2006-11-06 2017-05-02 Jina Pharmaceuticals, Inc. Guggulphospholipid methods and compositions
GB0905348D0 (en) * 2009-03-27 2009-05-13 Ucl Business Plc Carrier
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
CA2781529C (en) 2009-09-23 2017-10-24 Indu Javeri Methods for the preparation of liposomes comprising docetaxel
PL226015B1 (pl) * 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
US10188728B2 (en) 2012-12-12 2019-01-29 Temple University—Of the Commonwealth System of Higher Education Compositions and methods for treatment of cancer
US20160128971A1 (en) * 2013-04-05 2016-05-12 Vuong Trieu Nanoparticle Compositions
SG11201601311VA (en) * 2013-09-13 2016-03-30 Arbor Therapeutics Llc Nanoparticulate compositions for targeted delivery of lipophilic drugs and acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
ES2148223T3 (es) * 1992-03-23 2000-10-16 Univ Georgetown Taxol encapsulado en liposomas y metodo para su uso.
AU6833994A (en) * 1993-05-17 1994-12-12 Liposome Company, Inc., The Incorporation of taxol into liposomes and gels
JPH06329533A (ja) * 1993-05-20 1994-11-29 Kyowa Hakko Kogyo Co Ltd リポソーム製剤の製造法
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
DE4447770C2 (de) * 1994-08-20 2002-12-19 Max Delbrueck Centrum Verfahren zur Herstellung von liposomal verkapseltem Taxol
EP0792143B1 (en) * 1994-11-18 2002-09-04 Aphios Corporation Methods for making liposomes containing hydrophobic drugs
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
HU226325B1 (en) * 1995-09-12 2008-08-28 Cephalon Ltd Hydrolysis-promoting hydrophobic taxane derivatives, medicaments comprising them and the use of medicaments
US5756537A (en) * 1996-11-08 1998-05-26 Parkash S. Gill, M.D., Inc. Regime for paclitaxel in Kaposi's sarcoma patients

Also Published As

Publication number Publication date
EP1009384A1 (en) 2000-06-21
HUP0004583A3 (en) 2002-04-29
CN1275076A (zh) 2000-11-29
CA2301057A1 (en) 2000-01-13
NO20001012D0 (no) 2000-02-29
CA2301057C (en) 2009-03-10
EP1009384A4 (en) 2004-11-17
PL338951A1 (en) 2000-12-04
AU5088099A (en) 2000-01-24
TR200000576T1 (tr) 2000-11-21
KR20010023522A (ko) 2001-03-26
EA200000282A1 (ru) 2000-10-30
US6146659A (en) 2000-11-14
WO2000001366A1 (en) 2000-01-13
JP2001524990A (ja) 2001-12-04
SK4642000A3 (en) 2000-11-07
JP2004059590A (ja) 2004-02-26
AU730599B2 (en) 2001-03-08
NO20001012L (no) 2000-03-15
IL134747A0 (en) 2001-04-30
EA003678B1 (ru) 2003-08-28
NZ524490A (en) 2005-04-29
HUP0004583A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
BR9906581A (pt) Processo para administração de taxano encapsulado em lipossomos
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
PA8479201A1 (es) Derivados del acido hidroxi-pipecolato hidroxamico
BR0115162A (pt) Tratamentos antitumorais eficazes
BR0009647A (pt) Docetaxel em combinação com rhumab her2 para o tratamento de cânceres
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
HUP0002521A2 (hu) A paclitaxel ónium sói, eljárás előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények
BRPI0407897A (pt) derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
HK1102991A1 (en) Pharmaceutical formulation of decitabine
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
AU7031500A (en) Therapeutic quinazoline compounds
WO2002058694A3 (en) Method of treating hematologic tumors and cancers using beta lapachone
NO20040096L (no) Taxol-forbedringsforbindelser
BR0312845A (pt) Tetratiomolibdato de tetrapropilamÈnio e compostos relacionados para terapias antiangiogênicas
HK1068606A1 (en) Novel aminobenzoephenones
AR034223A1 (es) Novedosa indicacion terapeutica de azitromicina para el tratamiento de enfermedades inflamatorias no infecciosas
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
ATE233745T1 (de) Arzneistoffe
BR0214564A (pt) Processos de tratamento de câncer utilizando um inibidor da fpt e agentes antineoplásicos
BR0114856A (pt) Combinação compreendendo camptotecina e um derivado de estilbeno para o tratamento de câncer
BR0004813A (pt) Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori
SE0004827D0 (sv) Therapeutic compounds
MX9305152A (es) Metodo para el tratamiento de enfermedades obstructivas y reversibles de las vias respiratorias.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.